|
Aug 12
|
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know
|
|
Aug 12
|
Guggenheim Lifts PT on Regeneron Pharmaceuticals (REGN) to $815 From $810
|
|
Aug 12
|
Sanofi halts Praluent supply in China due to limited availability
|
|
Aug 12
|
Regeneron Reveals The Regeneron Prize For Creative Innovation 2025 Winners
|
|
Aug 11
|
3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
|
|
Aug 11
|
Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments
|
|
Aug 8
|
Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus
|
|
Aug 8
|
BMO Capital Lifts PT on Regeneron Pharmaceuticals (REGN) Stock, Keeps Outperform
|
|
Aug 6
|
Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y
|
|
Aug 5
|
Cisco Reinvents Digital Resilience for the Agentic Era at Splunk .conf25
|
|
Aug 4
|
Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)
|
|
Aug 4
|
Manufacturing issues at Novo facility disrupt Regeneron drug review
|
|
Aug 3
|
Regeneron Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 3
|
2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts
|
|
Aug 1
|
Colgate-Palmolive, Rocket, Regeneron: Trending Tickers
|
|
Aug 1
|
Why Regeneron (REGN) Stock Is Trading Up Today
|
|
Aug 1
|
Regeneron Stock Rises on Q2 Earnings and Sales Beat, Eylea HD Sales Up
|
|
Aug 1
|
Stocks Slump on Tariffs and Weak US Job Growth
|
|
Aug 1
|
Regeneron (REGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Aug 1
|
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
|